Docstoc

Future DES thrombosis trials

Document Sample
Future DES thrombosis trials Powered By Docstoc
					The STENT Thrombosis Study
10,000 consecutive patients receiving DES at up to 12 sites

Aspirin and clopidogrel responsiveness evaluated Using the Accumetrics VerifyNow system

Clinical Follow-Up for 2-5 years

Angiographic core lab assessment of all
stent thromboses and 1:3 matching controls

Supported by grants from Boston Scientific (lead contributor), Accumetrics, Abbott Vascular, Cordis, and Medtronic

www. Clinical trial results.org

Presented at TCT 2006

The E-Select Registry and INSIGHT Randomized Trial
30,000 patient global registry + U.S. randomized trial of standard vs. long duration clopidogrel Sponsor: Cordis Corp.

The PROTECT Randomized Trial
8,000 patient global randomized trial of the Endeavor vs.

the Cypher stent. Primary Endpoint = stent thrombosis
Sponsor: Medtronic Corp.
www. Clinical trial results.org
Presented at TCT 2006


				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:27
posted:4/23/2008
language:
pages:2